DIAPH3-AS1: A Promising Drug Target / Biomarker (G100874195)

Target Name: DIAPH3-AS1

NCBI ID: G100874195

DIAPH3-AS1

Other Name(s): DIAPH3-AS1 variant 2 | DIAPH3 antisense RNA 1 | DIAPH3 antisense RNA 1, transcript variant 2

DIAPH3-AS1: A Promising Drug Target / Biomarker

DIAPH3-AS1 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the diaphridin family, which is known for its role in the development and maintenance of tissues and organs. The identification and characterization of DIAPH3-AS1 as a potential drug target or biomarker has significant implications for the study of human diseases.

DIAPH3-AS1: Structure and Function

The diaphridin family of proteins is characterized by the presence of a dystrophin-like domain, which is responsible for the protein's structural stability and stability, as well as its ability to interact with other proteins. The dystrophin-like domain is composed of multiple amino acids that are similar to the dystrophin protein, which is a protein that is expressed in various tissues of the body, including the heart, lungs, and bones.

One of the unique features of DIAPH3-AS1 is its ability to form inclusion complexes with other proteins. These inclusion complexes can interact with various cellular signaling pathways, including the cAMP/cGMP signaling pathway. This interaction between DIAPH3-AS1 and signaling pathways is significant, as it suggests that DIAPH3-AS1 may play a role in the regulation of cellular processes that are important for human health and disease.

DIAPH3-AS1 has also been shown to interact with the protein p120GAP, which is a known co-factor of the protein p53. This interaction between DIAPH3-AS1 and p120GAP suggests that DIAPH3-AS1 may be involved in the regulation of cellular processes that are important for the maintenance of cellular homeostasis.

DIAPH3-AS1 has also been shown to interact with the protein CRL4-AS1. This interaction between DIAPH3-AS1 and CRL4-AS1 suggests that DIAPH3-AS1 may be involved in the regulation of cellular processes that are important for the development and maintenance of tissues and organs.

DIAPH3-AS1 as a Potential Drug Target

The identification of DIAPH3-AS1 as a potential drug target has significant implications for the study of human diseases. DIAPH3-AS1 has been shown to play a role in the regulation of cellular processes that are important for human health and disease. The interaction between DIAPH3-AS1 and signaling pathways, including the cAMP/cGMP signaling pathway, suggests that DIAPH3-AS1 may be involved in the regulation of cellular processes that are important for the maintenance of cellular homeostasis.

DIAPH3-AS1 may also be involved in the regulation of cellular processes that are important for the development and maintenance of tissues and organs. The interaction between DIAPH3-AS1 and CRL4-AS1 suggests that DIAPH3-AS1 may be involved in the regulation of cellular processes that are important for the formation and maintenance of tissues and organs.

DIAPH3-AS1 as a Potential Biomarker

The identification of DIAPH3-AS1 as a potential drug target or biomarker has significant implications for the study of human diseases. The regulation of cellular processes that are important for human health and disease is a complex process that is influenced by multiple factors, including genetic and environmental factors. The identification of DIAPH3-AS1 as a potential drug target or biomarker provides a new tool for the study of human diseases.

DIAPH3-AS1 may be a useful biomarker for the diagnosis and prognosis of various diseases, including heart disease, liver disease, and neurodegenerative diseases. The regulation of cellular processes that are important for these diseases may

Protein Name: DIAPH3 Antisense RNA 1

The "DIAPH3-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DIAPH3-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets